Literature DB >> 17952567

Synergic effects of polymeric additives on dissolution and crystallization of acetaminophen.

Hong Wen1, Kenneth R Morris, Kinam Park.   

Abstract

PURPOSE: To study how polymeric additives interact with the crystal surface of acetaminophen, and why they have different effects on drug crystallization and dissolution.
METHODS: The effects of different polymers on the etching patterns, crystallization and intrinsic dissolution rate (IDR) of acetaminophen have been studied.
RESULTS: Some polymers have shown clear consistency in their effects on the etching patterns, crystallization and IDR of acetaminophen. For example, hydroxypropyl cellulose (HPC), hydroxypropyl methylcellulose (HPMC) and polyvinylpyrrolidone (PVP), not only changed the etching patterns of the acetaminophen (010) face, but also inhibited acetaminophen crystallization significantly. Some polymers, like 2-hydroxyethyl cellulose (HEC), poly(vinyl alcohol) (PVA) and poly(ethylene glycol) (PEG) only had limited effects on the IDR and etching patterns, and no significant inhibitory effects on crystallization.
CONCLUSIONS: Even though some polymeric additives have no structural similarity to acetaminophen, they still can affect dissolution and crystallization of acetaminophen due to the synergic effects of their neighboring subunits during surface adsorption. The effects of polymeric additives on crystallization and dissolution of acetaminophen are affected not only by the specific interactions between adsorbed polymer molecules and crystal surface, but also by the mobility of the functional groups involved in the specific interactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952567     DOI: 10.1007/s11095-007-9468-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Influence of tailor-made additives on etching patterns of acetaminophen single crystals.

Authors:  T Li; K R Morris; K Park
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

2.  Hydrogen bonding interactions between adsorbed polymer molecules and crystal surface of acetaminophen.

Authors:  Hong Wen; Kenneth R Morris; Kinam Park
Journal:  J Colloid Interface Sci       Date:  2005-10-15       Impact factor: 8.128

3.  Study on the interactions between polyvinylpyrrolidone (PVP) and acetaminophen crystals: partial dissolution pattern change.

Authors:  Hong Wen; Kenneth R Morris; Kinam Park
Journal:  J Pharm Sci       Date:  2005-10       Impact factor: 3.534

4.  Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures.

Authors:  L S Taylor; G Zografi
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

5.  Crystallization of paracetamol from solution in the presence and absence of impurity.

Authors:  K V Prasad; R I Ristic; D B Sheen; J N Sherwood
Journal:  Int J Pharm       Date:  2001-03-14       Impact factor: 5.875

6.  Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions.

Authors:  L S Taylor; G Zografi
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

7.  Complexation of moricizine with nicotinamide and evaluation of the complexation constants by various methods.

Authors:  M A Hussain; R C DiLuccio; M B Maurin
Journal:  J Pharm Sci       Date:  1993-01       Impact factor: 3.534

  7 in total
  2 in total

1.  Influence of Hydroxypropyl Methylcellulose on Metronidazole Crystallinity in Spray-Congealed Polyethylene Glycol Microparticles and Its Impact with Various Additives on Metronidazole Release.

Authors:  Ching Mien Oh; Paul Wan Sia Heng; Lai Wah Chan
Journal:  AAPS PharmSciTech       Date:  2015-05-02       Impact factor: 3.246

2.  Influence of formulation and processing variables on properties of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution.

Authors:  Stephanie Bosselmann; Masao Nagao; Keat T Chow; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2012-06-30       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.